EP1877103A4 - Dendritic polymers with enhanced amplification and interior functionality - Google Patents

Dendritic polymers with enhanced amplification and interior functionality

Info

Publication number
EP1877103A4
EP1877103A4 EP05857843A EP05857843A EP1877103A4 EP 1877103 A4 EP1877103 A4 EP 1877103A4 EP 05857843 A EP05857843 A EP 05857843A EP 05857843 A EP05857843 A EP 05857843A EP 1877103 A4 EP1877103 A4 EP 1877103A4
Authority
EP
European Patent Office
Prior art keywords
dendritic polymers
enhanced amplification
interior functionality
functionality
interior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05857843A
Other languages
German (de)
French (fr)
Other versions
EP1877103A2 (en
Inventor
Donald A Tomalia
Douglas R Swanson
Baohua Huang
Verra Reddy Pulgam
Joseph R Heinzelmann
Sonke Svenson
Lori A Reyna
Michael A Zhuravel
Abhay Singh Chauhan
Cordell R Demattel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendritic Nanotechnologies Inc
Original Assignee
Dendritic Nanotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/013864 external-priority patent/WO2006065266A2/en
Application filed by Dendritic Nanotechnologies Inc filed Critical Dendritic Nanotechnologies Inc
Priority to EP10184062A priority Critical patent/EP2325236A1/en
Publication of EP1877103A2 publication Critical patent/EP1877103A2/en
Publication of EP1877103A4 publication Critical patent/EP1877103A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/005—Dendritic macromolecules
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0001—Post-treatment of organic pigments or dyes
    • C09B67/0004—Coated particulate pigments or dyes
    • C09B67/0008—Coated particulate pigments or dyes with organic coatings
    • C09B67/0013—Coated particulate pigments or dyes with organic coatings with polymeric coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Theoretical Computer Science (AREA)
  • Mathematical Physics (AREA)
  • Biochemistry (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
EP05857843A 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality Withdrawn EP1877103A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10184062A EP2325236A1 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2005/013864 WO2006065266A2 (en) 2004-04-20 2005-04-20 Dendritic polymers with enhanced amplification and interior functionality
PCT/US2005/047635 WO2006115547A2 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Publications (2)

Publication Number Publication Date
EP1877103A2 EP1877103A2 (en) 2008-01-16
EP1877103A4 true EP1877103A4 (en) 2010-11-03

Family

ID=37215167

Family Applications (2)

Application Number Title Priority Date Filing Date
EP05857843A Withdrawn EP1877103A4 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality
EP10184062A Withdrawn EP2325236A1 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP10184062A Withdrawn EP2325236A1 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Country Status (6)

Country Link
EP (2) EP1877103A4 (en)
JP (1) JP2008545621A (en)
CA (1) CA2598430C (en)
MX (1) MX2007010402A (en)
TW (1) TWI356709B (en)
WO (1) WO2006115547A2 (en)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1737899B1 (en) * 2004-04-20 2015-07-08 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality
US20090012033A1 (en) * 2006-03-03 2009-01-08 Demattei Cordell R Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers)
DE102006036326A1 (en) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritic polyglycerol sulfates and sulfonates and their use in inflammatory diseases
US20090324742A1 (en) * 2006-09-08 2009-12-31 Sonke Svenson Peham dendrimers as excipients
US7939095B2 (en) * 2006-12-21 2011-05-10 Cordis Corporation Crosslinked silane coating for medical devices
EP1958624A1 (en) * 2007-02-16 2008-08-20 Freie Universität Berlin Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy
FR2925505B1 (en) * 2007-12-24 2010-04-02 Arkema France PROCESS FOR THE PREPARATION OF A MATERIAL FORMED OF ARBORESCENT MOLECULES COMPRISING ASSOCIATIVE GROUPS
US8071679B2 (en) * 2008-02-29 2011-12-06 Ppg Industries Ohio, Inc Coating compositions comprising a polymer containing an oligomeric macromonomer
JP5093680B2 (en) * 2008-06-26 2012-12-12 独立行政法人産業技術総合研究所 Bisquaternary ammonium salt core type dendrimer
FR2935836B1 (en) 2008-09-08 2012-11-23 Commissariat Energie Atomique SEMICONDUCTOR NANOCRYSTALS
GB0901857D0 (en) * 2009-02-05 2009-03-11 Nanoco Technologies Ltd Encapsulated nanoparticles
IT1393368B1 (en) * 2009-03-23 2012-04-20 Dipharma Francis Srl METHOD FOR THE PREPARATION OF RUFINAMIDE
RU2612156C2 (en) * 2009-04-07 2017-03-02 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Nanoparticles mediated delivery of sequence-specific nucleases
JP2011055751A (en) * 2009-09-09 2011-03-24 Tokyo Univ Of Agriculture & Technology Method for preparing dendrimer-modified magnetic fine particle
US8247151B2 (en) 2009-10-19 2012-08-21 Hewlett-Packard Development Company, L.P. Liquid toner, electrophoretic ink, and methods of making and use
EP2493291B1 (en) * 2009-10-26 2019-05-22 Dendritic Nanotechnologies, Inc. Peham dendrimers for use in agriculture
US9296860B2 (en) 2009-12-21 2016-03-29 Dsm Assets B.V. Polymer, process and composition
EP3566719A1 (en) 2010-05-18 2019-11-13 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
FR2961208B1 (en) * 2010-06-09 2012-11-23 Oreal POLY 2-PYRROLIDONES FUNCTIONALIZED BY A RADICAL ESTER, ACID OR AMIDE, COSMETIC COMPOSITION COMPRISING SAME AND THEIR USE AS A DISPERSING AGENT
EA201390145A1 (en) * 2010-08-20 2013-11-29 Серулин Фарма Инк. CONJUGATES, PARTICLES, COMPOSITIONS AND RELATED METHODS
IT1402520B1 (en) * 2010-10-19 2013-09-13 Ivm Chemicals Srl NON-HARMFUL COATING ACTIVE AGAINST MICRO-ORGANISMS
CN103429267B (en) * 2011-01-09 2016-05-04 Anp科技公司 Branched polymer aggregate of hydrophobic molecule induction and uses thereof
WO2012174400A1 (en) * 2011-06-17 2012-12-20 Isp Investments Inc. 4-and 5-substituted 1,2,3-triazole and regioisomer mixtures thereof, modified polymers
EP2723799A1 (en) * 2011-06-21 2014-04-30 DSM IP Assets B.V. Polymer, process and use
US20140200333A1 (en) * 2011-08-15 2014-07-17 Seta Biomedicals, Llc Dendron reporter molecules
WO2013087789A1 (en) 2011-12-13 2013-06-20 Glykos Finland Ltd. Antibody isoform arrays and methods thereof
JP5920024B2 (en) * 2012-05-25 2016-05-18 Dic株式会社 Method for producing sulfonylamide compound containing fluorinated aliphatic group and method for producing anionic hydrophilic group-containing surfactant
CA2876304C (en) 2012-06-14 2021-07-20 Whitehead Institute For Biomedical Research Genome-wide method of assessing interactions between chemical entities and their target molecules
TWI524825B (en) 2012-10-29 2016-03-01 財團法人工業技術研究院 Method of transferring carbon conductive film
WO2014136906A1 (en) * 2013-03-06 2014-09-12 Ｊｘ日鉱日石エネルギー株式会社 Friction modifier and lubricating-oil composition
JP6564369B2 (en) * 2013-12-09 2019-08-21 デュレクト コーポレイション Pharmaceutically active agent conjugates, polymer conjugates, and compositions and methods involving them
WO2015177279A1 (en) 2014-05-21 2015-11-26 Ic Discovery Gmbh Therapeutic conjugates with sulfated dendrimers for intracellular targeting
US10202507B2 (en) 2014-05-29 2019-02-12 The University Of British Columbia Antithrombotic compounds, methods and uses thereof
CA2957721C (en) 2014-08-13 2021-04-13 The Johns Hopkins University Selective dendrimer delivery to brain tumors
WO2016040962A1 (en) * 2014-09-14 2016-03-17 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
US10968176B2 (en) 2014-09-14 2021-04-06 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
WO2016046847A1 (en) 2014-09-23 2016-03-31 Council Of Scientific & Industrial Research Metal embedded hydrophilic polymer for drug delivery applications
TWI557154B (en) * 2015-07-02 2016-11-11 國立臺灣科技大學 Supramolecular polymer and method for making same
CN104928919B (en) * 2015-07-10 2017-03-08 广州大学 A kind of softness Synergistic antimicrobial brush-type multi-quaternary ammonium salt fabric finishing agent and preparation method thereof
CA3008648C (en) 2015-12-16 2023-01-10 Priostar Pty Ltd Dendrimer and formulations thereof
CN110913916A (en) 2017-04-27 2020-03-24 约翰霍普金斯大学 Dendrimer composition for angiography
CA3082121C (en) 2017-11-10 2023-01-24 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
US11878969B2 (en) 2018-07-23 2024-01-23 Covestro (Netherlands) B.V. Multi-aziridine compound
US10954346B2 (en) 2018-12-27 2021-03-23 Industrial Technology Research Institute Resin and ink
CN113518757A (en) * 2019-03-13 2021-10-19 伊士曼化工公司 Method useful for making cyclododecithio
CN110694599A (en) * 2019-09-26 2020-01-17 浙江海洋大学 Preparation method of polypropylene imine modified magnetic nanocrystalline cellulose molecularly imprinted polymer
WO2021113662A2 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye
MX2022008983A (en) 2020-01-22 2022-08-11 Covestro Netherlands Bv Aziridine functional compound.
CN111440824B (en) * 2020-05-26 2022-07-12 北京化工大学 Liver-targeted cationic gene vector constructed based on lactose through amino-epoxy ring-opening reaction and preparation method thereof
CN111848969A (en) * 2020-07-27 2020-10-30 洛阳理工学院 Hyperbranched bifunctional star-shaped compound, polymer electrolyte material, preparation and application
CN113698549B (en) * 2021-09-03 2024-05-14 上海昶法新材料有限公司 Hyperbranched polymer, preparation method, application and washing product thereof
CN116023669B (en) * 2021-10-27 2023-12-15 兰州大学 Hybrid arm supermolecule star copolymer, and preparation method and application thereof
CN114044907B (en) * 2021-12-15 2022-11-11 兴宇汽车零部件股份有限公司 Intumescent flame retardant functionalized POSS flame retardant and preparation method thereof
CN114606190B (en) * 2022-03-08 2024-09-17 东南大学 Nanometer reagent for cell killing and bubble generation, cell micrometer vesicle, and preparation method and application thereof
CN114632194B (en) * 2022-04-11 2023-05-23 东莞市人民医院 Coating material with long-acting NO catalytic release and preparation method and application thereof
CN115044008B (en) * 2022-06-01 2024-01-05 武汉中科先进材料科技有限公司 Hydrophilic cationic photo-curing resin and preparation method and application thereof
CN115057552B (en) * 2022-06-23 2023-06-02 先导薄膜材料有限公司 Concentration method of low-concentration ammonium nitrate wastewater
CN115678271B (en) * 2022-11-02 2023-08-22 常州大学 Preparation method of bio-based polyamide plant dye masterbatch
CN116120575B (en) * 2023-01-09 2024-06-21 汕头大学 Silicon dioxide graft polymer and preparation method and application thereof
CN117946349B (en) * 2024-03-26 2024-07-09 潍坊弘润新材料有限公司 Dendritic polymer modified hydroxyl acrylic emulsion, preparation method and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271180A1 (en) * 1986-08-18 1988-06-15 The Dow Chemical Company Starburst conjugates
US5773527A (en) * 1990-08-27 1998-06-30 Dendritech, Inc. Non-crosslinked, polybranched polymers
WO2006065266A2 (en) * 2004-04-20 2006-06-22 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361337A (en) 1979-05-15 1982-11-30 Adriel Montes Piston ring with tongue and groove joint
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4631337A (en) 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
IL69558A (en) 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4740585A (en) 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US4735799A (en) 1987-01-14 1988-04-05 Patarroyo Manuel E Malaria vaccine
US5631329A (en) 1990-08-27 1997-05-20 Dendritech, Inc. Process for producing hyper-comb-branched polymers
IL128775A (en) 1994-03-07 2001-05-20 Dow Chemical Co Composition comprising a dendritic polymer in complex with at least one unit of biological response modifier and a process for the preparation thereof
SE503342C2 (en) * 1994-10-24 1996-05-28 Perstorp Ab Polyester-type hyperbranched macromolecule and process for its preparation
IT1277596B1 (en) * 1995-09-15 1997-11-11 Bracco Spa MACROMOLECULAR COMPOUNDS OF THE DENDRIMERIC TYPE
US5760142A (en) * 1996-12-04 1998-06-02 Dentsply Detrey G.M.B.H. Epoxide-amine dendrimers and the preparation and use thereof
FR2790642A1 (en) * 1999-03-08 2000-09-15 Aventis Cropscience Sa NEW PESTICIDE AND / OR REGULATORY GROWTH COMPOSITIONS
GB0125216D0 (en) * 2001-10-19 2001-12-12 Univ Strathclyde Dendrimers for use in targeted delivery
NO322724B1 (en) * 2004-04-15 2006-12-04 Sinvent As Process for preparing polybranched organic / inorganic hybrid polymer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271180A1 (en) * 1986-08-18 1988-06-15 The Dow Chemical Company Starburst conjugates
US5773527A (en) * 1990-08-27 1998-06-30 Dendritech, Inc. Non-crosslinked, polybranched polymers
WO2006065266A2 (en) * 2004-04-20 2006-06-22 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TANG L-M ET AL: "Structure, solution aggregation and UV curing of hyperbranched poly(ester-amine)s with terminal acrylate groups", POLYMER JOURNAL, SOCIETY OF POLYMER SCIENCE, TOKYO, JP LNKD- DOI:10.1295/POLYMJ.37.255, vol. 37, no. 4, 15 April 2005 (2005-04-15), pages 255 - 261, XP002567947, ISSN: 0032-3896 *
XU D ET AL: "Fast growing dendritic poly(ester-amines) from alternate reaction of EDA and TMPTA", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/J.TETLET.2005.01.180, vol. 46, no. 14, 4 April 2005 (2005-04-04), pages 2503 - 2505, XP004785784, ISSN: 0040-4039 *

Also Published As

Publication number Publication date
CA2598430C (en) 2011-10-25
CA2598430A1 (en) 2006-11-02
TW200801075A (en) 2008-01-01
WO2006115547A8 (en) 2007-02-15
JP2008545621A (en) 2008-12-18
EP2325236A1 (en) 2011-05-25
EP1877103A2 (en) 2008-01-16
WO2006115547A2 (en) 2006-11-02
TWI356709B (en) 2012-01-21
WO2006115547A3 (en) 2009-06-04
MX2007010402A (en) 2008-01-22

Similar Documents

Publication Publication Date Title
EP1877103A4 (en) Dendritic polymers with enhanced amplification and interior functionality
IL178715A0 (en) Dendritic polymers with enhanced amplification and interior functionality
EP2010584A4 (en) Grafted polymers and uses thereof
EP1970400A4 (en) Stimuli-responsive degradable gel
EP1853777A4 (en) Transition molding and installation methods therefor
GB2472542B (en) Nanoparticles
SI1996220T2 (en) Unstructured recombinant polymers and uses thereof
EP2032652A4 (en) Crosslinked, degradable polymers and uses thereof
EP1931334A4 (en) Functionalized drugs and polymers derived therefrom
EP2100477A4 (en) Speaker motor and speaker
EP1976546A4 (en) Cyclodextrin-containing polymers and uses thereof
EP1898832A4 (en) Fast degrading polymers
EP1731540A4 (en) Polymer particle
EP1719794A4 (en) Novel polymers and uses thereof
TWI371444B (en) Compound and polymer compound
EP1929010A4 (en) Polymer particles and uses thereof
GB0522660D0 (en) Assembly and device
EP1942129A4 (en) Cyanate ester polymer
ZA200804302B (en) 3-amlno-1-arylpropyl indoles and aza-substituted indoles
EP1862484A4 (en) Norbornene addition copolymer and moldings
ZA200803627B (en) Polymers incorporating 1,3 and 1,4 cyclohexnedimethanol
HU0800012V0 (en) Pendant case with incorporated freshener
EP1859968A4 (en) Electronic device and tire
GB0521992D0 (en) System design and manufacture
IL179510A0 (en) Dendritic polymers with enhanced amplification and interior functionality

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071120

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DEMATTEL, CORDELL, R.

Inventor name: HUANG, BAOHUA

Inventor name: TOMALIA, DONALD, A.

Inventor name: ZHURAVEL, MICHAEL, A.

Inventor name: SWANSON, DOUGLAS, R.

Inventor name: PULGAM, VERRA, REDDY

Inventor name: REYNA, LORI, A.

Inventor name: HEINZELMANN, JOSEPH, R.

Inventor name: SVENSON, SONKE

Inventor name: CHAUHAN, ABHAY, SINGH

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1116678

Country of ref document: HK

R17D Deferred search report published (corrected)

Effective date: 20090604

RIC1 Information provided on ipc code assigned before grant

Ipc: C08K 9/00 20060101ALI20090611BHEP

Ipc: C08J 3/00 20060101AFI20090611BHEP

Ipc: C08J 9/32 20060101ALI20090611BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101006

RIC1 Information provided on ipc code assigned before grant

Ipc: C08G 83/00 20060101AFI20100930BHEP

Ipc: A61K 47/48 20060101ALI20100930BHEP

Ipc: A61K 49/00 20060101ALI20100930BHEP

Ipc: A61K 48/00 20060101ALN20100930BHEP

17Q First examination report despatched

Effective date: 20110901

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1116678

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180703